Answers are grounded in this paper and cite their sources.
Evidence highlights rimegepant’s effectiveness in migraine prevention, suggesting potential for broader use.
Rimegepant represents a significant addition to migraine prophylaxis by offering a flexible and well-tolerated option that bridges acute and preventive care. Its role may expand through rational combinations and investigation in other headache disorders. Persistence and long-term safety require careful monitoring, and reimbursement frameworks will determine its future clinical adoption.
No takes yet. Share an insight, caveat, or question.
Pellesi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: